Incidence and Features of Acute Ischemic Stroke in Patients Hospitalized with COVID-19: A Multi-center Study in Turkey

Murat Mert Atmaca,Nazlı Gamze Bülbül,Miruna Florentina Ateş,Burcu Selbest,Fettah Eren,Sibel Güler,Uğur Burak Şimşek,Mehmet Fatih Yetkin,Merve Akcakoyunlu,Elif Özge Biçer,Soner Kılıç,Nur Aleyna Yetkin,Şazimet Taş,Zeynep Kocakaya,Kevser Karasu,Ufuk Yüksel,Ayşegül Ulu Kılıç,Zeynep Türe Yüce,Nuri Tutar,Burcu Baran Ketencioğlu,Kürşat Gündoğan,Şahin Temel,Murad Al Hasan,Şeyma Benli,Çağla Eröz,Ahmet Öztürk,Füsun Ferda Erdoğan

DOI: https://doi.org/10.29399/npa.28493

2024-07-24

Abstract:Introduction: Acute ischemic stroke (AIS) is a devastating complication of COVID-19 with high morbidity and mortality. In this study, we reported the frequency, characteristics, and outcome of AIS in patients with COVID-19. Methods: This multicenter and cross-sectional study was conducted between April 2020 and February 2021. Among the hospitalized patients with COVID-19, the detailed characteristics of those with and without AIS were recorded and compared. Results: Six hundred ninety-three patients were included in the study. Acute ischemic stroke was detected in 16 (2.31%) patients, the median age was 77 (range, 48-91) years, and 10 (62.5%) were female. The median NIHSS score at admission was 9 (range, 3-17). Total anterior circulation infarction (TACI) was the most common (37.5%) type and cardioembolism was the most common etiology (37.5%). Nine patients (56.25%) developed AIS within 24 hours of having COVID-19. COVID-19 severity was severe or critical in seven patients (43.75%). Eight patients died, and eight were discharged. Patients with AIS had a higher rate of hypertension, coronary artery disease, heart failure, a history of myocardial infarction, a history of cerebrovascular disease, severe and critical COVID-19, a higher mean age, and a longer ICU stay compared with those without AIS (p<0.001 for each). Conclusions: AIS can occur in patients with COVID-19 and is associated with mortality. Acute ischemic stroke is encountered at any stage of COVID-19, especially within the first 72 hours of the diagnosis, in older patients with comorbidities and severe COVID-19. There is an increased risk of AIS in patients with COVID-19 with a history of stroke.